Tamtam Try Tamtam free
Mativ logo

Mativ account plan

Specialty materials manufacturing solution

At a glance

Mativ is a Georgia-based specialty materials maker (filtration, films, tapes, papers) with FY2025 net sales of $1,987.0 million.

Mativ Holdings (NYSE: MATV) turns fibers, resins and chemicals into engineered nonwovens, films, specialty paper and netting, then coats, saturates and converts them for filtration, transportation, construction, healthcare, packaging and consumer goods customers. Formed by the 2022 merger of SWM and Neenah and headquartered in Alpharetta, Georgia, it runs 34 production locations on three continents and sells in over 100 countries. FY2025 net sales were $1,987.0 million (+0.3%), with a net loss of $337.4 million driven by a $411.9 million non-cash goodwill impairment, and adjusted EBITDA of $225 million. It has approximately 5,000 employees, 59% of them in North America.

Business units

Strategic priorities

Commercial excellence
A unified sales force across segments, a pipeline approach and pricing to recover input costs, against a $20 million to $25 million 2026 raw material headwind.
Balance sheet strengthening
Cut net leverage from 4.2x at end-2025 to the upper end of 2.5x-3.5x by mid-2027, using excess cash for debt reduction.
Portfolio optimization
Review assets, categories and facilities; the Wilson, North Carolina plant closed and a closed Appleton, Wisconsin facility was sold in November 2026 for approximately $7 million.
Cost savings
Nearly $20.0 million of savings delivered in 2025 and a next wave targeting $15.0 million to $20.0 million more by end of 2026.
Growth in FAM
Management expects FAM to grow faster than broad economic growth, led by commercial space films, paint protection films, aftermarket filtration and lignin-based filter media.
AI in commercial and manufacturing
Three core AI programmes to accelerate commercial growth, automate production scheduling and improve yield and reduce waste.

Latest results

In Q3 2026, net sales fell 2.8% to $499.5 million, as FAM grew 10.2% while SAS fell 10.9% after a July 27 tornado destroyed a third-party distribution facility in Menasha, Wisconsin. Operating profit rose to $19.9 million from $16.0 million and the net loss narrowed to $1.2 million; adjusted EBITDA was $62 million (-7%). Over nine months, sales were $1,510.9 million (-0.9%), gross margin rose to 19.6% from 18.1% and operating profit reached $62.5 million. For Q4, management expects adjusted EBITDA down low single digits year over year, and full-year 2026 revenue, earnings and cash generation ahead of 2025.

Investments and deals

April 2026 refinancing
A $305.0 million revolver, $89.9 million Term Loan A and $500.0 million Term Loan B replaced the bank facilities due in 2027; total debt was $976.4 million at September 30, 2026.
Capex
2026 capex guided at $45 million, roughly half growth and half efficiency and safety, after $40.0 million in 2025.
Commercial space films
Materials for a leading commercial space launch provider moved from qualification to commercial usage in Q3 2026, with scaling expected across 2027.
Miru smart-glass partnership
Energy-efficiency technology for automobiles and buildings, with sales mostly from 2027.

Challenges and risks

Menasha tornado
$42.5 million of inventory written off and a $20 million to $25 million Q3 2026 sales impact; insurance and business interruption recoveries are being pursued.
High leverage and interest cost
Net leverage was 3.8x at September 30, 2026, with 2026 interest of roughly $74 million and $400.0 million of 8.000% notes due 2029.
Raw material, energy and tariff costs
Resins, polymers, pulp and European energy are volatile, and a 50% Canadian tariff hits tapes exported from Renfrew, about 2% of revenue.
Weak end markets in SAS
Healthcare destocking expected through year end, with soft labels, automotive tapes and European release liners.

What leadership says

“we have transformed ourselves, and we are setting up our pivot to growth in 2027.”

Shruti Singhal, President and CEO · Q3 2026 earnings call (2026-11-05)

“Portfolio optimization remains a top priority for 2026.”

Shruti Singhal, President and CEO · Q4 and full year 2025 earnings call (2026-02-19)

“Mativ is a fundamentally better business than it was 12 months ago.”

Scott Minder, CFO · Q3 2026 earnings call (2026-11-05)

Where a supplier can help

Manufacturing AI and scheduling
The AI programmes for production scheduling, yield and waste, and predictive maintenance invite MES, analytics and industrial AI providers.
Warehousing and logistics resilience
The tornado forced a move to an interim network of three regional warehouses, opening room for 3PL, distribution and supply chain risk partners.
Procurement against raw material inflation
A $20 million to $25 million raw material headwind and energy volatility make sourcing, energy procurement and pricing tools relevant to the commercial excellence priority.
Capacity for FAM growth
Scaling commercial space films and lignin-based filter media through 2027 may need equipment, materials and engineering support within the growth half of capex.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Mativ?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Mativ

What does Mativ do?

Mativ makes specialty materials (filtration media, films, netting, tapes, release liners, specialty papers and healthcare materials) for manufacturers in over 100 countries.

What is Mativ's revenue?

FY2025 net sales were $1,987.0 million; Q3 2026 net sales were $499.5 million.

How many employees does Mativ have?

Approximately 5,000, with 59% in North America and 33% in Europe.

Who leads Mativ?

Shruti Singhal has been President and CEO since March 11, 2025, and Scott Minder became CFO on January 1, 2026.

What is Mativ's strategy?

Three pillars: commercial excellence, balance sheet strengthening and portfolio optimization, with a pivot to growth planned for 2027.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)